Fulgent Genetics (FLGT) vs Personalis (PSNL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Personalis (PSNL) has outperformed Fulgent Genetics (FLGT) over the past year, gaining 85.0% versus a loss of 8.8%. Over five years, PSNL leads with a -19.5% price change compared with -73.3% for FLGT. Personalis is the larger company by market cap ($1.72 billion vs $572.9 million), about 3.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FLGT | PSNL |
|---|---|---|
| Share price | $20.82 | $16.06 |
| Market cap | $572.87M | $1.72B |
| 1-day change | +1.22% | +0.37% |
| YTD return | -20.75% | +101.76% |
| 1-year return | -8.80% | +85.02% |
| 5-year return | -73.31% | -19.46% |
| EPS (TTM) | $-2.82 | $-1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $69.65M |
| Revenue growth (YoY) | — | -17.69% |
| Net income (latest FY) | — | $-81.27M |
| Gross margin | — | 22.65% |
| Operating margin | — | -126.43% |
| Net margin | — | -116.69% |
| 52-week high | $31.04 | $18.89 |
| 52-week low | $13.46 | $4.96 |
| Distance from 52-week high | -32.93% | -14.98% |
| Analyst consensus | none | hold |
| Avg. price target upside | -8.74% | -5.54% |
| Average volume | 301.04K | 3.53M |
| Shares outstanding | 27.52M | 106.80M |
| Employees | 1,315 | 259 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Personalis is about 3.0 times larger than Fulgent Genetics by market value ($1.72B vs $572.87M).
- PSNL has outperformed FLGT by 93.8 percentage points over the past year.
About Fulgent Genetics
FLGT stock →Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Health Care · Medical Specialities · 1,315 employees
About Personalis
PSNL stock →Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Health Care · Medical Specialities · 259 employees
FLGT vs PSNL FAQ
Which is bigger, Fulgent Genetics or Personalis?
Personalis (PSNL) is larger, with a market capitalization of $1.72B compared with $572.87M for Fulgent Genetics (FLGT).
Which stock has performed better over the past year, FLGT or PSNL?
PSNL returned +85.02% over the past 12 months, compared with -8.80% for FLGT (price return, excluding dividends). Past performance does not predict future results.
Are Fulgent Genetics and Personalis in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.